Search
Descriptor English: Gemifloxacin
Descriptor Spanish: Gemifloxacina
Descriptor gemifloxacino
Entry term(s) Factive
LB 20304
LB-20304
LB20304
SB 265805
SB-265805
SB265805
mesilato de gemifloxacina
ácido 7-(3-aminometil-4-metoxiimino-pirrolidin-1-il)-1-ciclopropil-6-fluoro-4-oxo-1,4-dihidro-(1,8)-naftiridina-3-carboxílico
Scope note: Antibacteriano derivado naftiridínico y fluoroquinolónico e inhibidor de la ADN TOPOISOMERASA II que se usa para el tratamiento de la neumonía adquirida en la comunidad y de las infecciones bacterianas agudas asociadas a bronquitis crónica.
Descriptor Portuguese: Gemifloxacina
Descriptor French: Gémifloxacine
Entry term(s): 7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
Factive
Gemifloxacin Mesylate
LB 20304
LB-20304
LB20304
SB 265805
SB-265805
SB265805
Tree number(s): D03.633.100.612.250
D03.633.100.810.835.322.322
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077735
Scope note: A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Anti-Bacterial Agents
Topoisomerase II Inhibitors
Registry Number: OKR68Y0E4T
CAS Type 1 Name: 1,8-Naphthyridine-3-carboxylic acid, 7-((4Z)-3-(aminomethyl)-4-(methoxyimino)-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-
Public MeSH Note: 2019; GEMIFLOXACIN was indexed under NAPHTHYRIDINES and FLUOROQUINOLONES 1997-2018
History Note: 2019 (1997)
DeCS ID: 57740
Unique ID: D000077735
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/07/03
Gemifloxacin - Preferred
Concept UI M0370050
Scope note A naphthyridine and fluoroquinolone derivative antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used for the treatment of community-acquired pneumonia and acute bacterial infections associated with chronic bronchitis.
Preferred term Gemifloxacin
7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid - Broader
Concept UI M000641396
Preferred term 7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine-3-carboxylic acid
Factive - Narrower
Concept UI M0501647
Preferred term Factive
Gemifloxacin Mesylate - Narrower
Concept UI M0468774
Preferred term Gemifloxacin Mesylate
SB-265805 - Narrower
Concept UI M0270088
Preferred term SB-265805
Entry term(s) SB 265805
SB265805
LB 20304 - Narrower
Concept UI M0270089
Preferred term LB 20304
Entry term(s) LB-20304
LB20304



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey